Fielmann Aktiengesellschaft (FLMNF)

USD 43.0

(0.0%)

Net Income Summary of Fielmann Aktiengesellschaft

  • Fielmann Aktiengesellschaft's latest annual net income in 2023 was 127.64 Million EUR , up 23.14% from previous year.
  • Fielmann Aktiengesellschaft's latest quarterly net income in 2024 Q2 was 43.99 Million EUR , up 4.16% from previous quarter.
  • Fielmann Aktiengesellschaft reported an annual net income of 103.65 Million USD in 2022, down -24.26% from previous year.
  • Fielmann Aktiengesellschaft reported an annual net income of 136.85 Million USD in 2021, up 17.56% from previous year.
  • Fielmann Aktiengesellschaft reported a quarterly net income of 43.99 Million EUR for 2024 Q2, up 4.16% from previous quarter.
  • Fielmann Aktiengesellschaft reported a quarterly net income of 127.64 Million EUR for 2023 FY, up 23.14% from previous quarter.

Annual Net Income Chart of Fielmann Aktiengesellschaft (2023 - 2002)

Historical Annual Net Income of Fielmann Aktiengesellschaft (2023 - 2002)

Year Net Income Net Income Growth
2023 127.64 Million EUR 23.14%
2022 103.65 Million USD -24.26%
2021 136.85 Million USD 17.56%
2020 116.4 Million USD -32.4%
2019 172.2 Million USD 1.96%
2018 168.88 Million EUR 0.75%
2017 167.62 Million EUR 0.79%
2016 166.3 Million EUR 0.47%
2015 165.53 Million EUR 5.22%
2014 157.31 Million EUR 13.98%
2013 138.02 Million EUR 9.23%
2012 126.36 Million EUR 3.4%
2011 122.2 Million EUR 3.75%
2010 117.78 Million EUR 5.12%
2009 112.04 Million EUR 1.27%
2008 110.64 Million EUR 34.86%
2007 82.04 Million EUR 18.8%
2006 69.06 Million EUR 25.46%
2005 55.04 Million EUR 24.18%
2004 44.32 Million EUR -36.8%
2003 70.14 Million EUR 56.0%
2002 44.96 Million EUR 0.0%

Peer Net Income Comparison of Fielmann Aktiengesellschaft

Name Net Income Net Income Difference
American Medical Technologies Inc. -926.89 Thousand USD 13871.169%
Ansell Limited 76.5 Million USD -66.855%
Ansell Limited 76.5 Million USD -66.855%
BG Medicine, Inc. - USD -Infinity%
Biotage AB (publ) 24.28 Million USD -425.712%
BioLife Sciences Inc. - USD -Infinity%
CB Scientific, Inc. -1.63 Million USD 7929.753%
Psykey, Inc. -1.32 Million USD 9741.142%
ConvaTec Group Plc 130.3 Million USD 2.038%
ConvaTec Group Plc 130.3 Million USD 2.038%
Encision Inc. -691.78 Thousand USD 18551.451%
Golden Valley Development, Inc -141.81 Thousand USD 90109.943%
Hear AtLast Holdings, Inc. -234.36 Thousand USD 54563.531%
Innovative MedTech Inc. -7.93 Million USD 1707.83%
LifePoint, Inc. -15.23 Million USD 938.021%
Medite Cancer Diagnostics, Inc. -6.81 Million USD 1974.086%
Paradigm Medical Industries, Inc. -474 Thousand USD 27029.114%
QuantRx Biomedical Corporation - USD -Infinity%
Remedent, Inc. -274.44 Thousand USD 46609.696%
Reflect Scientific, Inc. -459.02 Thousand USD 27907.454%
SmileDirectClub, Inc. -86.4 Million USD 247.729%
Sector 10, Inc. 7036.00 USD -1814055.77%
Shandong Weigao Group Medical Polymer Company Limited 2 Billion USD 93.624%
SheerVision, Inc. -71.37 Thousand USD 178933.221%
United Health Products, Inc. -2.62 Million USD 4965.841%
Vasamed, Inc. -4.88 Million USD 2711.293%
Wearable Health Solutions, Inc. -2.38 Million USD 5444.181%
Yubo International Biotech Limited -1.2 Million USD 10694.929%